Bank of New York Mellon’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
CA
ST
HC
CA
GCP
N
QC
Bank of New York Mellon's NAUT Position: Q2 2026 in Review
Bank of New York Mellon opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 122,570 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #4103 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in NAUT as recently as Q1 2025.
Bank of New York Mellon first reported a position in NAUT in Q3 2021 and has held it in 16 quarters since. The position peaked at $578K in Q2 2023. 37 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.
- Bank of New York Mellon held 122,570 shares of Nautilus Biotechnolgy worth $229K as of Q2 2026.
- Nautilus Biotechnolgy was a new Bank of New York Mellon position in Q2 2026.
- Nautilus Biotechnolgy made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4103 holding.
- Bank of New York Mellon first reported a position in Nautilus Biotechnolgy in Q3 2021 and has held it in 16 quarters since.
- Bank of New York Mellon's Nautilus Biotechnolgy position peaked at $578K in Q2 2023.
- 37 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.